Fungus Resistance In Patients With Blood Cancer Receiving Antifungal Treatment

Main Article Content

Rajesh Singh
Dr. Vaibhav Sharma

Abstract

According to a large number of authorities, India is the epicentre of the diabetes pandemic that is sweeping the world. Indians had a higher incidence of insulin resistance, abdominal obesity, low adiponectin, and high C-reactive protein levels compared to other ethnic groups. The number of individuals living with diabetes is projected to rise from 61.9 million in 2021 to 70.1 million in 2025, as stated in the Diabetes Atlas 2021 published by the International Diabetes Federation. Steroids, which may be given either orally or intravenously, tacrolimus, and mycophenolate mofetil are all examples of medications that belong to the class that is being questioned here. These medications were used in the treatment of autoimmune conditions such as SLE and RPGN, among others. The majority of individuals diagnosed with blood cancer were required to undergo long-term catheterization as well as antibiotic treatment. This was in addition to the substantial danger that they already posed. According to the findings of a Chi-Square test, candiduria caused by C. tropicalis is much more likely to occur after transplantation. Because the significance level for this test is set at 0.003, the findings should be considered significant. Those who suffered from chronic renal impairment had 36 percent more frequent cases of urinary tract infections (CKD).

Article Details

How to Cite
Fungus Resistance In Patients With Blood Cancer Receiving Antifungal Treatment. (2024). Innovative Journal of Medical and Healthcare Research, 1(1), 32-35. https://www.ijmhr.com/index.php/ijmhr/article/view/4
Section
Articles

How to Cite

Fungus Resistance In Patients With Blood Cancer Receiving Antifungal Treatment. (2024). Innovative Journal of Medical and Healthcare Research, 1(1), 32-35. https://www.ijmhr.com/index.php/ijmhr/article/view/4